Answers are grounded in this paper and cite their sources.
cost-efficient alternative to sequencing techniques, providing global methylome information without the need for extensive bioinformatic analyses. Several studies focused on biomarker discovery in human disease. Zhou et al. applied a nontargeted metabolomics approach with high-resolution mass spectrometry to investigate the mechanisms of icariin in the treatment of rheumatoid arthritis. They identified 31 potential biomarkers to diagnose metabolic disorders in rheumatoid arthritis, 23 of which were regulated by icariin, through pathways including the glutamate, arachidonic acid, pyruvate metabolism, the citrate cycle, glycolysis, etc., implicating oxidative stress and inflammation. Concomitantly, Masood et al. conducted a complementary investigation of rheumatoid arthritis using untargeted high-resolution mass spectrometry on 122 human plasma samples. They identified 300 dysregulated metabolites, ultimately annotating 60 endogenous metabolites with strong separation between rheumatoid arthritis patients and controls. They found major metabolic changes in the lipid, amino acid, and nucleotide metabolism pathways linked to cytokines, the MAPK pathway, etc., that supported plasma metabolomics as a phenotyping tool to find candidate biomarkers to diagnose rheumatoid arthritis. Wan et al. examined carotid atherosclerosis using metabolomics, spatial metabolomics, and single-cell transcriptomics with MALDI-MSI. They identified 74 differential metabolites between stable and unstable plaques of the patients, with arachidonic acid as the main inflammation-causing lipid upregulated in unstable plaques and enriched in 22 metabolic pathways. Spatial MALDI-MSI directly localized arachidonic acid with inflammatory macrophages, and single-cell analysis highlighted ELOVL5 and ALOX5 as over-expressed macrophage genes, offering mechanistic information on the linoleic acid -arachidonic acid -leukotriene D4 metabolic axis within atherosclerotic plaques. Dong et al. employed metabolomics to identify early biomarkers to detect acute intra-abdominal infection. They enrolled 30 patients and 20 healthy controls and analyzed their serum and urine samples with high-resolution mass spectrometry. They identified five serum biomarkers linked to fatty acid biosynthesis pathway, and two urinary biomarkers linked to catecholamine biosynthesis pathway. They proposed these candidates as diagnostic biomarkers for the early diagnosis of acute intra-abdominal infection. Zhang et al. developed and validated a rapid triple quadrupole mass spectrometric method for the simultaneous quantification of 11 antimicrobials in human plasma, achieving baseline separation of the components within eight minutes. They validated the method according to regulatory guidelines, meeting the requirements for clinical therapeutic drug monitoring implementation. They successfully applied the procedure to measure plasma samples of pediatric patients receiving mono-or combination antibiotic therapy, building strategies for timely therapeutic drug monitoring in the clinic. From the point of inflammation care, aging, and plant-based therapeutics, Xie et al. used untargeted metabolomics with high-resolution mass spectrometry to investigate Cuscutae Semen in a mouse model of depression-induced ovarian dysfunction. They identified ten differential metabolites from various pathways including arachidonic acid metabolism and steroid hormone biosynthesis, with seven target genes further validating their findings. The results supported Cuscutae Semen as a functional medical food with defined pharmacological mechanisms. Li et al. employed high-resolution mass spectrometry, non-targeted metabolomics, network pharmacology, and molecular dynamics to study Taohong Siwu Decoction in carbon tetrachloride-induced hepatic fibrosis. They identified 45 blood components, 148 differential metabolites, and a target network pointing to PI3K-Akt, MAPK, and estrogen signaling. They found ferulic acid derivatives as emerging key active compounds, with 3-hydroxy-4methoxycinnamic acid showing stable binding to PPARG. Ying et al. took a transcriptomic approach to sarcopenia, integrating several public datasets to identify a three-gene mitochondrial signature, validating them in vitro, and achieving a high diagnostic area-under-the-curve (AUC) score. Their nomogram model emphasized the role of mitochondrial dysfunction in muscle aging and offered a potential clinical tool for early sarcopenia detection. Working on clinical and respiratory applications, Gisler et al. explored real-time breath analysis using secondary electrospray ionization coupled with high-resolution mass spectrometry in 128 children (tobacco-exposed and non-exposed) and found that 71 breath features significantly correlated with the urinary oxidative stress marker 8-iso-PGF2α. They could not detect a strong correlation between predicted and measured values, but the study supported breath metabolomics as a promising non-invasive tool to indicate oxidative stress. Likewise, Shajari et al. monitored the inflammatory bowel disease activity in 174 stool proteomics samples obtained by highresolution mass spectrometry with data-independent analysis. A nine-peptide panel from five proteins, selected within a leakage-free nested cross-validation framework, achieved an outerfold AUC of 0.93. More importantly, the panel retained diagnostic power (AUC 0.80) even in the calprotectin "gray zone," where current non-invasive tests were unreliable. From the bibliometric perspective, Wu et al. provided a broader context through the analysis of 1,188 publications on osteosarcoma metabolomics from 1995 to 2024. China leads in output, with growing interest in extracellular vesicles, immune metabolism, and single-cell metabolomics, reflecting a field-wide shift toward higher-resolution metabolic characterization and translational application. Finally, Szeitz et al. hosted a two-part roundtable discussion where they brought together representatives from the mass spectrometry industry to highlight recent developments, research requirements, and regulatory guidelines on mass spectrometry instrumentation and technology. In the first part, the panelists explored current trends in mass spectrometry focusing on research applications and gaps, single-cell analysis, metabolomics, lipidomics, and multi-omics integration, while in the second part, they examined data management, bioinformatics, collaboration and industry needs. They sought to integrate mindsets within scientific research, inspire diverse perspectives, and foster scientific discourse with mass spectrometry transforming the landscape of medical science and molecular research. Taken together, these studies showcase how metabolomics, integrated with genomics, proteomics, spatial imaging, and machine learning, is becoming central to mechanistic biology, clinical diagnostics, and therapeutic discovery through various biological systems. Author contributions AS: Conceptualization, Investigation, Methodology, Writing -original draft, Writing -review and editing. JP: Methodology, Writing -original draft, Writing -review and editing. AP: Methodology, Writing -original draft, Writing -review and editing. Funding The author(s) declared that financial support was not received for this work and/or its publication. Acknowledgments
No takes yet. Share an insight, caveat, or question.
Szeitz et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: